MARC details
| 000 -LEADER |
|---|
| fixed length control field |
07553cam a22003014a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231012130550.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
090617s2010 moua b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781416062493 (pbk. : alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1416062491 (pbk. : alk. paper) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
BUL |
| Transcribing agency |
BUL |
| Modifying agency |
BUL |
| Language of cataloging |
eng |
| Description conventions |
rda |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
QV 4 L523p 2010 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lehne, Richard A., |
| Dates associated with a name |
1943- |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Pharmacology for nursing care / |
| Statement of responsibility, etc. |
Richard A. Lehne ; in consultation with Linda A. Moore, Leanna J. Crosby, Diane B. Hamilton. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
7th edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
St. Louis, Mo. : |
| Name of publisher, distributor, etc. |
Saunders/Elsevier, |
| Date of publication, distribution, etc. |
c2010. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiv, 1362 p. : |
| Other physical details |
ill. (chiefly col.) ; |
| Dimensions |
29 cm. + |
| Accompanying material |
1 CD-ROM (4 3/4 in.) |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Contents<br/><br/>I. Introduction 1. Orientation to pharmacology --<br/>2. Application of pharmacology in nursing practice --<br/>3. Drug regulation, development, names, and information <br/><br/> II. Basic principles of pharmacology --<br/>4. Pharmacokinetics --<br/>5. Pharmacodynamics --<br/>6. Drug interactions --<br/>7. Adverse drug reactions and medication errors --<br/>8. Individual variation in drug responses --<br/><br/> III. Drug therapy across the lifespan --<br/>9. Drug therapy during pregnancy and breast-feeding --<br/>10. Drug therapy in pediatric patients --<br/>11. Drug therapy in geriatric patients. <br/><br/> IV. Peripheral nervous system drugs --<br/>Introduction --<br/>12. Basic principles of neuropharmacology --<br/>13. Physiology of the peripheral nervous system --<br/>Cholinergic drugs --<br/>14. Muscarinic agonists and antagonists --<br/>15. Cholinesterase inhibitors and their use in myasthenia gravis --<br/>16. Drugs that block nicotinic cholinergic transmission : neuromuscular blocking agents and ganglionic blocking agents --<br/>Adrenergic drugs --<br/>17. Adrenergic agonists --<br/>18. Adrenergic antagonists --<br/>19. Indirect-acting antiadrenergic agents. <br/><br/>V. Central nervous system drugs --<br/>20. Introduction to central nervous system pharmacology --<br/>Drugs for neurodegenerative disorders --<br/>21. Drugs for Parkinson's disease --<br/>22. Alzheimer's disease --<br/>23. Drugs for multiple sclerosis --<br/>Neurologic drugs --<br/>24. Drugs for epilepsy --<br/>25. Drugs for muscle spasm and spasticity --<br/>Drugs for pain --<br/>26. Local anesthetics --<br/>27. General anesthetics --<br/>28. Opioid (narcotic) analgesics, opioid antagonists, and nonopioid centrally acting analgesics --<br/>29. Pain management in patients with cancer --<br/>30. Drugs for headache --<br/>Psychotherapeutic drugs --<br/>31. Antipsychotic agents and their use in schizophrenia --<br/>32. Antidepressants --<br/>33. Drugs for bipolar disorder --<br/>34. Sedative-hypnotic drugs --<br/>35. Management of anxiety disorders --<br/>36. Central nervous system stimulants and attention-deficit/hyperactivity disorder. Drug abuse --<br/>37. Drug abuse I : basic considerations --<br/>38. Drug abuse II : alcohol --<br/>39. Drug abuse III : major drugs of abuse (other than alcohol) --<br/><br/>VI. Drugs that affect fluid and electrolyte balance --<br/>40. Diuretics --<br/>41. Agents affecting the volume and ion content of body fluids<br/><br/>VII. Drugs that affect the heart, blood vessels, and blood --<br/>42. Review of hemodynamics --<br/>43. Drugs acting on the renin-angiotensin-aldosterone system --<br/>44. Calcium channel blockers --<br/>45. Vasodilators --<br/>46. Drugs for hypertension --<br/>47. Drugs for heart failure --<br/>48. Antidysrhythmic drugs --<br/>49. Prophylaxis of coronary heart disease : drugs that help normalize cholesterol and triglyceride levels --<br/>50. Drugs for angina pectoris --<br/>51. Anticoagulant, antiplatelet, and thrombolytic drugs --<br/>52. Management of ST-elevation myocardial infarction --<br/>53. Drugs for hemophilia --<br/>54. Drugs for deficiency anemias --<br/>55. Hematopoietic growth factors. [Pt]. VIII. Drugs for endocrine disorders --<br/>56. Drugs for diabetes mellitus --<br/>57. Drugs for thyroid disorders --<br/>58. Drugs related to hypothalamic and pituitary function --<br/>59. Drugs for disorders of the adrenal cortex <br/><br/>IX. Women's health --<br/>60. Estrogens and progestins : basic pharmacology and noncontraceptive applications --<br/>61. Birth control --<br/>62. Drug therapy of infertility --<br/>63. Drugs that affect uterine function <br/><br/> X. Men's health --<br/>64. Androgens --<br/>65. Drugs for erectile dysfunction and benign prostatic hyperplasia <br/><br/>XI. Anti-inflammartory, antiallergic, and immunologic drugs --<br/>66. Review of the immune system --<br/>67. Childhood immunization --<br/>68. Immunosuppressants --<br/>69. Antihistamines --<br/>70. Cyclooxygenase inhibitors : nonsteroidal anti-inflammatory drugs and acetaminophen <br/>71. Glucocorticoids in nonendocrine diseases<br/><br/>XII. Drugs for bone and joint disorders --<br/>72. Drug therapy of rheumoatoid arthritis and gout --<br/>73. Drug therapy of gout --<br/>74. Drugs affecting calcium levels and bone mineralization. [Pt]. XIII. Respiratory tract drugs --<br/>75. Drugs for asthma --<br/>76. Drugs for allergic rhinitis, cough, and colds <br/><br/>XIV. Gastrointestinal drugs --<br/>77. Drugs for peptic ulcer disease --<br/>78. Laxatives --<br/>79. Other gastrointestinal drugs <br/><br/>XV. Nutrition --<br/>80. Vitamins --<br/>81. Drugs for obesity <br/><br/>XVI. Chemotherapy of infectious diseases --<br/>82. Basic principles of antimicrobial therapy --<br/>83. Drugs that weaken the bacterial cell wall 1 : penicillins --<br/>84. Drugs that weaken the bacterial cell wall 2 : cephalosporins, carbapenems, Vancomycin, Aztreonam, Teicoplanin, and Fosfomycin --<br/>85. Bacteriostatic inhibitors of protein synthesis : tetracyclines, macrolides and others --<br/>86. Aminoglycosides : bactericidal inhibitors of protein synthesis --<br/>87. Sulfonamides and trimethoprim --<br/>88. Drug therapy of urinary tract infections --<br/>89. Antimycobacterial agents : drugs for tuberculosis, leprosy, and mycobacterium avium complex infection --<br/>90. Miscellaneous antibacterial drugs : fluoroquinolones, metronidazole, daptomycin, rifampin, bacitracin, and polymyxins --<br/>91. Antifungal agents --<br/>92. Antiviral agents 1 : drugs for non-HIV viral infections --<br/>93. Antiviral agents 2 : drugs for HIV infection and related opportunistic infections --<br/>94. Drug therapy of sexually transmitted diseases --<br/>95. Antiseptics and disinfectants. [Pt]. XVII. Chemotherapy of parasitic diseases --<br/>96. Anthelmintics --<br/>97. Antiprotozoal drugs 1: antimalarial agents --<br/>98. Antiprotozoal drugs 2 : miscellaneous agents --<br/>99. Ectoparasiticides <br/><br/>XVIII. Cancer chemotherapy --<br/>100. Basic principles of cancer chemotherapy --<br/>101. Anticancer drugs I: cytotoxic agents --<br/>102. Anticancer drugs II : hormonal agents, biologic response modifiers, and targeted drugs<br/><br/>XIX. Additional important drugs --<br/>103. Drugs for the eye --<br/>104. Drugs for the skin --<br/>105. Drugs for the ear --<br/>106. Miscellaneous noteworthy drugs <br/><br/>XX. Alternative therapy --<br/>107. Dietary supplements <br/><br/> XXI. Toxicology --<br/>108. Management of poisoning --<br/>109. Potential weapons of biologic, radiologic, and chemical terrorism. Appendixes --<br/>A. Adult immunization --<br/>B. Guide to gender-related drugs --<br/>C. Commonly used abbreviations --<br/>D. Canadian drug information --<br/>E. Major drug classes and their prototypes --<br/>F. Very new drugs and important new formulations of older drugs. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Nursing. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology |
| Form subdivision |
Nurses' Instruction. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug Therapy |
| Form subdivision |
Nurses' Instruction. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmaceutical Preparations |
| Form subdivision |
Nurses' Instruction. |
| 655 #0 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
CD-ROMs |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Book Open Access |
| Edition |
7th edition |
| Classification part |
QV 4 L523p 2010 |
| Item part |
1 |
| Call number prefix |
QV 4 |
| Call number suffix |
L523p 2010 |
